Treatment of multiple sclerosis by oral administration of bovine myelin
US5849298A · kind A · utility
52Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 10, 1993 |
| Grant date | Dec 15, 1998 |
| Priority date | — |
| Expiry date | Aug 10, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/543
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to a method of treating multiple sclerosis in animals, including humans, by the oral administration of bovine myelin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.